Measles-containing-vaccine second-dose (MCV2) immunization coverage in Gambia
Gambia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 78.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Gambia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Gambia recorded 78.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
The figure is down 6.0% on the previous year and up 1.3% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Gambia peaked at 83.0% in 2024 and was at its lowest, 0.0%, in 2000.
Gambia ranks 117th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Gambia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 56.0% | — |
| 2013 | 53.0% | -5.4% |
| 2014 | 73.0% | +37.7% |
| 2015 | 77.0% | +5.5% |
| 2016 | 79.0% | +2.6% |
| 2017 | 68.0% | -13.9% |
| 2018 | 71.0% | +4.4% |
| 2019 | 61.0% | -14.1% |
| 2020 | 61.0% | +0.0% |
| 2021 | 61.0% | +0.0% |
| 2022 | 52.0% | -14.8% |
| 2023 | 73.0% | +40.4% |
| 2024 | 83.0% | +13.7% |
| 2025 | 78.0% | -6.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 53.8% | 0.0% | 79.0% | 10 |
| 2020s | 68.0% | 52.0% | 83.0% | 6 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Heat deaths vs projected death rates 1,044 (2090)
- Un projection of annual infant deaths 700 (2100)
- Population ages 15-64, male, annual growth rate 3.07 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.2832 units per person (2025)
- Population ages 15-64, total, annual growth rate 3 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0006 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.5709 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Gambia?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Gambia was 78.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Gambia?
- The highest recorded value was 83.0% in 2024.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Gambia?
- The lowest recorded value was 0.0% in 2000.
- How does Gambia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Gambia ranks 117th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Gambia?
- Over the last ten years it is up 1.3%. The long-run trend across the full record is volatile.
- Where does this Gambia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).